ELAVL2 and ovarian carcinoma: Furthermore, it was recently reported that ELAVL2 and ELAVL4 activated glycolysis pathway under glucose deprivation condition and their high expression levels were responsible for the development of chemoresistance to paclitaxel in ovarian cancer cells39.